Gentechnologische Medikamente und Gentherapie. [Gene technology drugs and gene therapy]

Détails

ID Serval
serval:BIB_B03B315C9320
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Gentechnologische Medikamente und Gentherapie. [Gene technology drugs and gene therapy]
Périodique
Therapeutische Umschau
Auteur⸱e⸱s
Blum  H. E., Moradpour  D.
ISSN
0040-5930 (Print)
Statut éditorial
Publié
Date de publication
12/1999
Volume
56
Numéro
12
Pages
730-7
Notes
English Abstract
Journal Article
Review --- Old month value: Dec
Résumé
The principles of recombinant DNA technology are illustrated based on the biology of somatic cells with transcription of chromosomal DNA into messenger RNA and its translation into protein. Recombinant DNA technology allows the cloning, identification and characterization of genes and their expression with the production of medically relevant proteins. The products of recombinant DNA technology are cloned genes on the one hand. These may be useful for molecular diagnosis and gene therapy. On the other hand they comprise recombinant proteins which may be useful in the diagnosis, therapy and prevention of human diseases.
Mots-clé
Animals Cloning, Molecular Forecasting Gene Therapy/*trends Humans Recombinant Proteins/*therapeutic use
Pubmed
Création de la notice
25/01/2008 17:05
Dernière modification de la notice
20/08/2019 16:19
Données d'usage